HF
EXAS

HRT Financial’s Exact Sciences EXAS Stock Holding History

HRT Financial’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-99,672
Closed -$10.1M – 4063
2025
Q4 		$10.1M Buy
99,672
+83,208
+505% +$6.68M 0.03% 459
2025
Q3 		$900K Buy
+16,464
New +$823K ﹤0.01% 1582
2025
Q1 		– Sell
-31,245
Closed -$1.75M – 2749
2024
Q4 		$1.75M Sell
31,245
-33,707
-52% -$2.1M 0.01% 797
2024
Q3 		$4.42M Buy
+64,952
New +$3.67M 0.02% 518
2024
Q2 		– Sell
-77,232
Closed -$4.25M – 2460
2024
Q1 		$5.33M Buy
77,232
+72,462
+1,519% +$4.58M 0.03% 245
2023
Q4 		$352K Sell
4,770
-8,080
-63% -$530K ﹤0.01% 1550
2023
Q3 		$876K Buy
+12,850
New +$1.09M 0.01% 1069
2023
Q2 		– Sell
-7,362
Closed -$499K – 2687
2023
Q1 		$499K Sell
7,362
-91,338
-93% -$5.87M 0.01% 1391
2022
Q4 		$4.89M Buy
+98,700
New +$4.03M 0.07% 272
2021
Q4 		– Sell
-53,085
Closed -$5.07M – 3430
2021
Q3 		$5.07M Buy
+53,085
New +$5.6M 0.03% 316
2021
Q2 		– Sell
-14,010
Closed -$1.85M – 3032
2021
Q1 		$1.85M Buy
+14,010
New +$1.92M 0.02% 664
2020
Q4 		– Sell
-4,062
Closed -$414K – 2022
2020
Q3 		$414K Buy
+4,062
New +$351K 0.01% 970
2018
Q3 		– Sell
-10,053
Closed -$601K – 434
2018
Q2 		$601K Buy
+10,053
New +$541K 0.22% 80

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

HRT Financial's EXAS Position: Q1 2026 in Review

HRT Financial sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 99,672 shares — an estimated $10.1M sold.

HRT Financial first reported a position in EXAS in Q2 2018 and held it in 13 quarters. The position peaked at $10.1M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • HRT Financial reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 99,672 Exact Sciences shares in Q1 2026, an estimated $10.1M.
  • HRT Financial first reported a position in Exact Sciences in Q2 2018 and held it in 13 quarters.
  • HRT Financial's Exact Sciences position peaked at $10.1M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.